(Total Views: 124)
Posted On: 10/29/2021 11:55:47 AM
Post# of 104187
$ABBV News Article - AbbVie's Cariprazine (VRAYLAR ) Met Primary Endpoint in Phase 3 Study as an Adjunctive Treatment for Major Depressive Disorder https://marketwirenews.com/news-releases/abbv...41235.html
(0)
(0)
My Twitter: WhyteStocks
Scroll down for more posts ▼
